No profile data available.
QuidelOrtho Corporation (QDEL) is a healthcare company in the additional medical testing equipment industry, based in San Diego, United States, with about 6,500 full-time employees.
It reported revenue of $2.73 billion for fiscal year 2025, down 1.9% from fiscal year 2024, and net income of -$1.13 billion. In Q1 2026 (the quarter ended March 31, 2026) revenue was $619.80 million, down 10.5% from a year before. North America was its largest region in fiscal year 2025, with 55% of revenue. Its market capitalization was $920.28 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
QuidelOrtho reported $2.73 billion in revenue for fiscal year 2025, down 1.9% from $2.78 billion in fiscal year 2024. In Q1 2026 revenue was $619.80 million.
North America: 55% of revenue by region in fiscal year 2025, followed by EMEA (13%).
$920.28 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Bio-Rad Laboratories, Inc. (BIO), Exagen Inc. (XGN), Global Cord Blood Corporation (CORBF), Biomerica, Inc. (BMRA).